{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:42:35Z","timestamp":1769064155461,"version":"3.49.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0573-8","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T08:00:49Z","timestamp":1506412849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Per os colchicine administration in cholesterol fed rabbits: Triglycerides lowering effects without affecting atherosclerosis progress"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0893-9381","authenticated-orcid":false,"given":"Vaios Vasileios","family":"Kaminiotis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Agrogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Androutsopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laskarina Maria","family":"Korou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis S.","family":"Vlachos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismene A.","family":"Dontas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despina","family":"Perrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios C.","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"key":"573_CR1","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(06)68770-9","volume":"367","author":"AD Lopez","year":"2006","unstructured":"Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747\u201357.","journal-title":"Lancet"},{"key":"573_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","volume":"105","author":"P Libby","year":"2002","unstructured":"Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135\u201343.","journal-title":"Circulation"},{"key":"573_CR3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","volume":"17","author":"C Weber","year":"2011","unstructured":"Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17:1410\u201322.","journal-title":"Nat Med"},{"key":"573_CR4","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","volume":"464","author":"P Duewell","year":"2010","unstructured":"Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nu\u00f1ez G, Schnurr M. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357\u201361.","journal-title":"Nature"},{"key":"573_CR5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.chemphyslip.2010.05.084","volume":"163","author":"K Rajam\u00e4ki","year":"2010","unstructured":"Rajam\u00e4ki K, Lappalainen J, \u00d6\u00f6rni K, V\u00e4lim\u00e4ki E, Matikainen S, Kovanen PT, Eklund KK. Cholesterol crystals activate the NLRP3 inflammasome in human monocytes and macrophages. Chem Phys Lipids. 2010;163:S27\u20138.","journal-title":"Chem Phys Lipids"},{"key":"573_CR6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ni.2711","volume":"14","author":"FJ Sheedy","year":"2013","unstructured":"Sheedy FJ, Moore KJ. IL-1 signaling in atherosclerosis: sibling rivalry. Nat Immunol. 2013;14:1030\u20132.","journal-title":"Nat Immunol"},{"key":"573_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev-immunol-031210-101405","volume":"29","author":"BK Davis","year":"2011","unstructured":"Davis BK, Wen H, Ting JPY. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol. 2011;29:707.","journal-title":"Annu Rev Immunol"},{"key":"573_CR8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","volume":"66","author":"F Merhi-Soussi","year":"2005","unstructured":"Merhi-Soussi F, Kwak BR, Magne D, Chadjichristos C, Berti M, Pelli G, James RW, Mach F, Gabay C. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res. 2005;66:583\u201393.","journal-title":"Cardiovasc Res"},{"key":"573_CR9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","volume":"104","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Besnard S, Les\u00e8che G, Chvatchko Y, Tedgui A. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation. 2001;104:1598\u2013603.","journal-title":"Circulation"},{"key":"573_CR10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ni.1935","volume":"11","author":"SL Masters","year":"2010","unstructured":"Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 [beta] in type 2 diabetes. Nat Immunol. 2010;11:897\u2013904.","journal-title":"Nat Immunol"},{"key":"573_CR11","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/nm.3265","volume":"19","author":"T Jourdan","year":"2013","unstructured":"Jourdan T, Godlewski G, Cinar R, Bertola A, Szanda G, Liu J, Tam J, Han T, Mukhopadhyay B, Skarulis MC. Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes. Nat Med. 2013;19:1132\u201340.","journal-title":"Nat Med"},{"key":"573_CR12","doi-asserted-by":"crossref","first-page":"16852","DOI":"10.1073\/pnas.0607917103","volume":"103","author":"EC Lewis","year":"2006","unstructured":"Lewis EC, Dinarello CA. Responses of IL-18-and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor. Proc Natl Acad Sci. 2006;103:16852\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"573_CR13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000057959","volume":"57","author":"S Frigerio","year":"2002","unstructured":"Frigerio S, Holl\u00e4nder GA, Zumsteg U. Functional IL-18 is produced by primary pancreatic mouse islets and NIT-1 beta cells and participates in the progression towards destructive insulitis. Hormone Res Paediatr. 2002;57:94\u2013104.","journal-title":"Hormone Res Paediatr"},{"key":"573_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bbadis.2015.10.022","volume":"1862","author":"A Hoffmann","year":"2016","unstructured":"Hoffmann A, Ebert T, Kl\u00f6ting N, Dokas J, Jeromin F, Jessnitzer B, Burkhardt R, Fasshauer M, Kralisch S. Leptin dose-dependently decreases atherosclerosis by attenuation of hypercholesterolemia and induction of adiponectin. Biochim Biophys Acta (BBA)-Mol Basis Dis. 2016;1862:113\u201320.","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"573_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00011-006-0087-8","volume":"55","author":"M Kjerrulf","year":"2006","unstructured":"Kjerrulf M, Berke Z, Aspegren A, Umaerus M, Nilsson T, Svensson L, Hurt-Camejo E. Reduced cholesterol accumulation by leptin deficient (ob\/ob) mouse macrophages. Inflamm Res. 2006;55:300\u20139.","journal-title":"Inflamm Res"},{"key":"573_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1083\/jcb.25.1.145","volume":"25","author":"EW Taylor","year":"1965","unstructured":"Taylor EW. The mechanism of colchicine inhibition of mitosis I. Kinetics of inhibition and the binding of H3-colchicine. J Cell Biol. 1965;25:145\u201360.","journal-title":"J Cell Biol"},{"key":"573_CR17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","volume":"61","author":"SM Nidorf","year":"2013","unstructured":"Nidorf SM, Eikelboom JW, Budgeon CA, Thompson PL. Low-dose colchicine for secondary prevention of cardiovascular disease. J Am Coll Cardiol. 2013;61:404\u201310.","journal-title":"J Am Coll Cardiol"},{"key":"573_CR18","doi-asserted-by":"crossref","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","volume":"4","author":"GJ Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez GJ, Robertson S, Barraclough J, Xia Q, Mallat Z, Bursill C, Celermajer DS, Patel S. Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome. J Am Heart Assoc. 2015;4:e002128.","journal-title":"J Am Heart Assoc"},{"key":"573_CR19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","volume":"14","author":"T Misawa","year":"2013","unstructured":"Misawa T, Takahama M, Kozaki T, Lee H, Zou J, Saitoh T, Akira S. Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome. Nat Immunol. 2013;14:454\u201360.","journal-title":"Nat Immunol"},{"key":"573_CR20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","volume":"128","author":"A Slobodnick","year":"2015","unstructured":"Slobodnick A, Shah B, Pillinger MH, Krasnokutsky S. Colchicine: old and new. Am J Med. 2015;128:461\u201370.","journal-title":"Am J Med"},{"key":"573_CR21","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00726-009-0340-x","volume":"38","author":"AE Yanni","year":"2010","unstructured":"Yanni AE, Agrogiannis G, Nomikos T, Fragopoulou E, Pantopoulou A, Antonopoulou S, Perrea D. Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit. Amino Acids. 2010;38:1323\u201331.","journal-title":"Amino Acids"},{"key":"573_CR22","doi-asserted-by":"crossref","unstructured":"Ibrahim M, Mikail MA, Ahmed IA, Hazali N, Rasad MSBA, Ghani RA, Hashim R, Arief SJ, Isa MLM, Draman S. Comparison of the effects of three different Baccaurea angulata whole fruit juice doses on plasma, aorta and liver MDA levels, antioxidant enzymes and total antioxidant capacity. Eur J Nutr. 2017:1\u201312. \nhttps:\/\/doi.org\/10.1007\/s00394-017-1466-3\n\n.","DOI":"10.1007\/s00394-017-1466-3"},{"key":"573_CR23","doi-asserted-by":"crossref","first-page":"31525","DOI":"10.3402\/fnr.v60.31525","volume":"60","author":"TA Rahman","year":"2016","unstructured":"Rahman TA, Hassim NF, Zulkafli N, Muid S, Kornain NK, Nawawi H. Atheroprotective effects of pure tocotrienol supplementation in the treatment of rabbits with experimentally induced early and established atherosclerosis. Food Nutr Res. 2016;60:31525.","journal-title":"Food Nutr Res"},{"key":"573_CR24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0023677214544184","volume":"48","author":"AE Yanni","year":"2014","unstructured":"Yanni AE. Laboratory rabbit and high-cholesterol diet: what is taken for granted may not be so simple. Lab Anim. 2014;48:349\u201350.","journal-title":"Lab Anim"},{"key":"573_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0021-9150(73)90134-2","volume":"17","author":"C Cavallero","year":"1973","unstructured":"Cavallero C, Di Tondo U, Mingazzini PL, Pesando PC, Spagnoli LG. Cell proliferation 1n the atherosclerotic lesions of cholesterol-fed rabbits: part 2. histological, ultrastructural and radidautographic observations on epinephrine-treated rabbits. Atherosclerosis. 1973;17:49\u201362.","journal-title":"Atherosclerosis"},{"key":"573_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(71)90003-7","volume":"13","author":"C Cavallero","year":"1971","unstructured":"Cavallero C, Turolla E, Ricevuti G. Cell proliferation in the atherosclerotic plaques of cholesterol-fed rabbits: part 1. colchicine and [3H] thymidine studies. Atherosclerosis. 1971;13:9\u201320.","journal-title":"Atherosclerosis"},{"key":"573_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(97)00161-5","volume":"135","author":"G Finking","year":"1997","unstructured":"Finking G, Hanke H. Nikolaj Nikolajewitsch Anitschkow (1885\u20131964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis. 1997;135:1\u20137.","journal-title":"Atherosclerosis"},{"key":"573_CR28","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1161\/01.ATV.16.12.1454","volume":"16","author":"FD Kolodgie","year":"1996","unstructured":"Kolodgie FD, Katocs AS, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, Lee SJ, Virmani R. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol. Arterioscler Thromb Vasc Biol. 1996;16:1454\u201364.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0021-9150(79)90202-8","volume":"33","author":"W Hollander","year":"1979","unstructured":"Hollander W, Paddock J, Nagraj S, Colombo M, Kirkpatrick B. Effects of anticalcifying and antifibrobrotic drugs on pre-established atherosclerosis in the rabbit. Atherosclerosis. 1979;33:111\u201323.","journal-title":"Atherosclerosis"},{"key":"573_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bbrc.2012.07.058","volume":"425","author":"F Usui","year":"2012","unstructured":"Usui F, Shirasuna K, Kimura H, Tatsumi K, Kawashima A, Karasawa T, Hida S, Sagara J, Si T, Takahashi M. Critical role of caspase-1 in vascular inflammation and development of atherosclerosis in Western diet-fed apolipoprotein E-deficient mice. Biochem Biophys Res Commun. 2012;425:162\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"573_CR31","doi-asserted-by":"crossref","unstructured":"Viola J, Soehnlein O. Atherosclerosis\u2013a matter of unresolved inflammation. In: Seminars in immunology: Resolution of inflammation. Edited by Mauro Perretti. Elsevier; 2015;27(3):145\u2013234.","DOI":"10.1016\/j.smim.2015.03.013"},{"key":"573_CR32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pbiomolbio.2016.05.001","volume":"121","author":"C Baumgartner","year":"2016","unstructured":"Baumgartner C, Brandl J, M\u00fcnch G, Ungerer M. Rabbit models to study atherosclerosis and its complications\u2013transgenic vascular protein expression in vivo. Prog Biophys Mol Biol. 2016;121:131\u201341.","journal-title":"Prog Biophys Mol Biol"},{"key":"573_CR33","first-page":"I131","volume":"34","author":"W Hollande","year":"1974","unstructured":"Hollande W, Kramsch DM, Franzbla C, Paddock J, Colombo MA. Suppression of atheromatous fibrous plaque-formation by antiproliferative and antiinflammatory drugs. Circ Res. 1974;34:I131\u201341.","journal-title":"Circ Res"},{"key":"573_CR34","first-page":"343","volume":"38","author":"J W\u00f3jcicki","year":"1985","unstructured":"W\u00f3jcicki J, Hinek A, Jaworska M, Samochowiec L. The effect of colchicine on the development of experimental atherosclerosis in rabbits. Pol J Pharmacol Pharm. 1985;38:343\u20138.","journal-title":"Pol J Pharmacol Pharm"},{"key":"573_CR35","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(76)90028-9","volume":"25","author":"WM Lee","year":"1976","unstructured":"Lee WM, Morrison ES, Scott RF, Lee KT, Kroms M. Effects of methyl prednisolone and colchicine on the development of aortic atherosclerosis in swine. Atherosclerosis. 1976;25:213\u201324.","journal-title":"Atherosclerosis"},{"key":"573_CR36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P Libby","year":"2011","unstructured":"Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317\u201325.","journal-title":"Nature"},{"key":"573_CR37","first-page":"11","volume":"80","author":"JW Currier","year":"1989","unstructured":"Currier JW, Pow TK, Minihan AC, Haudenschild CC, Faxon DP, Ryan TJ. Colchicine inhibits restenosis after iliac angioplasty in the atherosclerotic rabbit. Circulation. 1989;80:11\u201366.","journal-title":"Circulation"},{"key":"573_CR38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jss.2007.04.029","volume":"146","author":"HM Atta","year":"2008","unstructured":"Atta HM, El-Rehany MA, Raheim SRA, Fouad R, Galal AMF. Colchicine inhibits intimal hyperplasia and leukocyte VEGF expression in dogs. J Surg Res. 2008;146:184\u20139.","journal-title":"J Surg Res"},{"key":"573_CR39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arcmed.2015.01.004","volume":"46","author":"J Kong","year":"2015","unstructured":"Kong J, Deng Y, Dong Q, Liu W, Lu Y. Colchicine reduces restenosis after balloon angioplasty treatment for in-stent restenosis. Arch Med Res. 2015;46:101\u20136.","journal-title":"Arch Med Res"},{"key":"573_CR40","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","volume":"61","author":"S Deftereos","year":"2013","unstructured":"Deftereos S, Giannopoulos G, Raisakis K, Kossyvakis C, Kaoukis A, Panagopoulou V, Driva M, Hahalis G, Pyrgakis V, Alexopoulos D. Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients. J Am Coll Cardiol. 2013;61:1679\u201385.","journal-title":"J Am Coll Cardiol"},{"key":"573_CR41","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","volume":"19","author":"JH O\u2019Keefe","year":"1992","unstructured":"O\u2019Keefe JH, McCallister BD, Bateman TM, Kuhnlein DL, Ligon RW, Hartzler GO. Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty. J Am Coll Cardiol. 1992;19:1597\u2013600.","journal-title":"J Am Coll Cardiol"},{"key":"573_CR42","first-page":"213","volume":"41","author":"UN Das","year":"1993","unstructured":"Das UN. Colchicine in diabetes mellitus. J Assoc Physicians India. 1993;41:213.","journal-title":"J Assoc Physicians India"},{"key":"573_CR43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.clinthera.2015.03.010","volume":"37","author":"L Wang","year":"2015","unstructured":"Wang L, Sawhney M, Zhao Y, Carpio GR, Fonseca V, Shi L. Association between colchicine and risk of diabetes among the veterans affairs population with gout. Clin Ther. 2015;37:1206\u201315.","journal-title":"Clin Ther"},{"key":"573_CR44","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.14.11.1767","volume":"14","author":"JH Rapp","year":"1994","unstructured":"Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweedie-Hardman J, Kotite L, Kunitake ST, Havel RJ, Kane JP. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 1994;14:1767\u201374.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.3.1.2","volume":"3","author":"RE Pitas","year":"1983","unstructured":"Pitas RE, Innerarity TL, Mahley RW. Foam cells in explants of atherosclerotic rabbit aortas have receptors for beta-very low density lipoproteins and modified low density lipoproteins. Arterioscler Thromb Vasc Biol. 1983;3:2\u201312.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2006.09.015","volume":"193","author":"GD Norata","year":"2007","unstructured":"Norata GD, Grigore L, Raselli S, Redaelli L, Hamsten A, Maggi F, Eriksson P, Catapano AL. Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: molecular mechanisms and gene expression studies. Atherosclerosis. 2007;193:321\u20137.","journal-title":"Atherosclerosis"},{"key":"573_CR47","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/01.ATV.19.4.1051","volume":"19","author":"F-Y Jin","year":"1999","unstructured":"Jin F-Y, Kamanna VS, Kashyap ML. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells. Arterioscler Thromb Vasc Biol. 1999;19:1051\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.nutr.23.011702.073102","volume":"23","author":"NL Urizar","year":"2003","unstructured":"Urizar NL, Moore DD. GUGULIPID: a natural cholesterol-lowering agent. Annu Rev Nutr. 2003;23:303\u201313.","journal-title":"Annu Rev Nutr"},{"key":"573_CR49","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjcard.2011.04.015","volume":"108","author":"HE Bays","year":"2011","unstructured":"Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN. Eicosapentaenoic acid ethyl ester (AMR101) therapy in patients with very high triglyceride levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] trial). Am J Cardiol. 2011;108:682\u201390.","journal-title":"Am J Cardiol"},{"key":"573_CR50","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.109.154047","volume":"330","author":"AJ King","year":"2009","unstructured":"King AJ, Segreti JA, Larson KJ, Souers AJ, Kym PR, Reilly RM, Zhao G, Mittelstadt SW, Cox BF. Diacylglycerol acyltransferase 1 inhibition lowers serum triglycerides in the Zucker fatty rat and the hyperlipidemic hamster. J Pharmacol Exp Ther. 2009;330:526\u201331.","journal-title":"J Pharmacol Exp Ther"},{"key":"573_CR51","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1161\/01.ATV.0000168417.52486.56","volume":"25","author":"H Yamagami","year":"2005","unstructured":"Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, Nagai Y, Hori M. Associations of serum IL-18 levels with carotid intima-media thickness. Arterioscler Thromb Vasc Biol. 2005;25:1458\u201362.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR52","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/hh0202.105292","volume":"90","author":"SC Whitman","year":"2002","unstructured":"Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 mice through release of interferon-\u03b3. Circ Res. 2002;90:e34\u20138.","journal-title":"Circ Res"},{"key":"573_CR53","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","volume":"106","author":"S Blankenberg","year":"2002","unstructured":"Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24\u201330.","journal-title":"Circulation"},{"key":"573_CR54","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/hh1901.098735","volume":"89","author":"Z Mallat","year":"2001","unstructured":"Mallat Z, Corbaz A, Scoazec A, Graber P, Alouani S, Esposito B, Humbert Y, Chvatchko Y, Tedgui A. Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res. 2001;89:e41\u20135.","journal-title":"Circ Res"},{"key":"573_CR55","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","volume":"56","author":"RM Pope","year":"2007","unstructured":"Pope RM, Tschopp J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum. 2007;56:3183\u20138.","journal-title":"Arthritis Rheum"},{"key":"573_CR56","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","volume":"130","author":"S Robertson","year":"2016","unstructured":"Robertson S, Martinez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci. 2016;130:1237\u201346.","journal-title":"Clin Sci"},{"key":"573_CR57","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","volume":"2","author":"P Menu","year":"2011","unstructured":"Menu P, Pellegrin M, Aubert JF, Bouzourene K, Tardivel A, Mazzolai L, Tschopp J. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. Cell Death Dis. 2011;2:e137.","journal-title":"Cell Death Dis"},{"key":"573_CR58","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","volume":"108","author":"S Blankenberg","year":"2003","unstructured":"Blankenberg S, Luc G, Ducimeti\u00e8re P, Arveiler D, Ferri\u00e8res J, Amouyel P, Evans A, Cambien F, Tiret L. Interleukin-18 and the risk of coronary heart disease in European men. Circulation. 2003;108:2453\u20139.","journal-title":"Circulation"},{"key":"573_CR59","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00125-009-1455-z","volume":"52","author":"MF Hivert","year":"2009","unstructured":"Hivert MF, Sun Q, Shrader P, Mantzoros CS, Meigs JB, Hu FB. Circulating IL-18 and the risk of type 2 diabetes in women. Diabetologia. 2009;52:2101\u20138.","journal-title":"Diabetologia"},{"key":"573_CR60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s001250051619","volume":"44","author":"F Nicoletti","year":"2001","unstructured":"Nicoletti F, Conget I, Di Marco R, Speciale AM, Morinigo R, Bendtzen K, Gomis R. Serum levels of the interferon-\u03b3-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia. 2001;44:309\u201311.","journal-title":"Diabetologia"},{"key":"573_CR61","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10753-014-9878-1","volume":"37","author":"M Ryba-Stanis\u0142awowska","year":"2014","unstructured":"Ryba-Stanis\u0142awowska M, Rybarczyk-Kapturska K, My\u015bliwiec M, My\u015bliwska J. Elevated levels of serum IL-12 and IL-18 are associated with lower frequencies of CD4+ CD25highFOXP3+ regulatory t cells in young patients with type 1 diabetes. Inflammation. 2014;37:1513\u201320.","journal-title":"Inflammation"},{"key":"573_CR62","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cyto.2008.02.006","volume":"42","author":"AE Altinova","year":"2008","unstructured":"Altinova AE, Yetkin I, Akbay E, Bukan N, Arslan M. Serum IL-18 levels in patients with type 1 diabetes: relations to metabolic control and microvascular complications. Cytokine. 2008;42:217\u201321.","journal-title":"Cytokine"},{"key":"573_CR63","first-page":"732","volume":"44","author":"G Dong","year":"2007","unstructured":"Dong G, Liang L, Fu J, Zou C. Serum interleukin-18 levels are raised in diabetic ketoacidosis in Chinese children with type 1 diabetes mellitus. Indian Pediatr. 2007;44:732.","journal-title":"Indian Pediatr"},{"key":"573_CR64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/dc06-1768","volume":"30","author":"N Katakami","year":"2007","unstructured":"Katakami N, Kaneto H, Matsuhisa M, Yoshiuchi K, Kato K, Yamamoto K, Umayahara Y, Kosugi K, Hori M, Yamasaki Y. Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients. Diabetes Care. 2007;30:159\u201361.","journal-title":"Diabetes Care"},{"key":"573_CR65","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.2337\/diacare.26.5.1647","volume":"26","author":"K Esposito","year":"2003","unstructured":"Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care. 2003;26:1647.","journal-title":"Diabetes Care"},{"key":"573_CR66","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molimm.2014.12.012","volume":"64","author":"RZ Harms","year":"2015","unstructured":"Harms RZ, Yarde DN, Guinn Z, Lorenzo-Arteaga KM, Corley KP, Cabrera MS, Sarvetnick NE. Increased expression of IL-18 in the serum and islets of type 1 diabetics. Mol Immunol. 2015;64:306\u201312.","journal-title":"Mol Immunol"},{"key":"573_CR67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-07-0206","volume":"157","author":"JM Bruun","year":"2007","unstructured":"Bruun JM, Stallknecht B, Helge JW, Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol. 2007;157:465\u201371.","journal-title":"Eur J Endocrinol"},{"key":"573_CR68","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.clim.2005.07.008","volume":"117","author":"CP Fischer","year":"2005","unstructured":"Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK. Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol. 2005;117:152\u201360.","journal-title":"Clin Immunol"},{"key":"573_CR69","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/01.ATV.0000163843.70369.12","volume":"25","author":"J Hung","year":"2005","unstructured":"Hung J, McQuillan BM, Chapman CML, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol. 2005;25:1268\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-9-11","volume":"9","author":"M Tr\u00f8seid","year":"2010","unstructured":"Tr\u00f8seid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol. 2010;9:1.","journal-title":"Cardiovasc Diabetol"},{"key":"573_CR71","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/oby.2006.248","volume":"14","author":"GP Guilder","year":"2006","unstructured":"Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, DeSouza CA. Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity. 2006;14:2127\u201331.","journal-title":"Obesity"},{"key":"573_CR72","first-page":"15","volume-title":"Seminars in vascular medicine","author":"RV Considine","year":"2005","unstructured":"Considine RV. Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. In: Seminars in vascular medicine. New York: Copyright\u00a9 2005 by Thieme Medical Publishers, Inc.; 2005. p. 15\u201324."},{"key":"573_CR73","doi-asserted-by":"crossref","first-page":"E496","DOI":"10.1152\/ajpendo.00509.2007","volume":"294","author":"DJ Lloyd","year":"2008","unstructured":"Lloyd DJ, McCormick J, Helmering J, Kim KW, Wang M, Fordstrom P, Kaufman SA, Lindberg RA, V\u00e9niant MM. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48\u2212\/\u2212 Lepob\/ob mice devoid of ApoE or Ldlr. Am J Physiol Endocrinol Metab. 2008;294:E496\u2013505.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"573_CR74","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2012.10.031","volume":"225","author":"JY Jun","year":"2012","unstructured":"Jun JY, Ma Z, Pyla R, Segar L. Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2+\/Akita: apoE\u2212\/\u2212 mice. Atherosclerosis. 2012;225:341\u20137.","journal-title":"Atherosclerosis"},{"key":"573_CR75","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/01.CIR.0000056523.08033.9F","volume":"107","author":"A Mertens","year":"2003","unstructured":"Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice. Circulation. 2003;107:1640\u20136.","journal-title":"Circulation"},{"key":"573_CR76","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1161\/01.ATV.0000173306.47722.ec","volume":"25","author":"PF Bodary","year":"2005","unstructured":"Bodary PF, Gu S, Shen Y, Hasty AH, Buckler JM, Eitzman DT. Recombinant leptin promotes atherosclerosis and thrombosis in apolipoprotein E\u2013deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:e119\u201322.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR77","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/ATVBAHA.109.195255","volume":"29","author":"M Zeadin","year":"2009","unstructured":"Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apolipoprotein E\u2013deficient mice. Arterioscler Thromb Vasc Biol. 2009;29:2069\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"573_CR78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2007.01.040","volume":"196","author":"T Chiba","year":"2008","unstructured":"Chiba T, Shinozaki S, Nakazawa T, Kawakami A, Ai M, Kaneko E, Kitagawa M, Kondo K, Chait A, Shimokado K. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice. Atherosclerosis. 2008;196:68\u201375.","journal-title":"Atherosclerosis"},{"key":"573_CR79","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1161\/01.ATV.0000105904.02142.e7","volume":"24","author":"K Sch\u00e4fer","year":"2004","unstructured":"Sch\u00e4fer K, Halle M, Goeschen C, Dellas C, Pynn M, Loskutoff DJ, Konstantinides S. Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol. 2004;24:112\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0573-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T08:01:24Z","timestamp":1506412884000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0573-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0573-8","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,26]]},"article-number":"184"}}